Alzamend Neuro, Inc. (ALZN) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2026 | $1.35M | +112.1% |
| 2025 | $634.8K | -80.3% |
| 2024 | $3.23M | +12.4% |
| 2023 | $2.87M | +146.4% |
| 2022 | $1.16M | +29.5% |
| 2021 | $899.6K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2026 | $1.35M | +112.1% |
| 2025 | $634.8K | -80.3% |
| 2024 | $3.23M | +12.4% |
| 2023 | $2.87M | +146.4% |
| 2022 | $1.16M | +29.5% |
| 2021 | $899.6K | — |